n-methyl-3,4-methylenedioxyamphetamine has been researched along with humulene in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.22) | 18.7374 |
1990's | 4 (4.88) | 18.2507 |
2000's | 43 (52.44) | 29.6817 |
2010's | 26 (31.71) | 24.3611 |
2020's | 8 (9.76) | 2.80 |
Authors | Studies |
---|---|
Appler, WD; Beck, DC | 1 |
Clark, JC; Forrest, AR; Galloway, JH; Marsh, ID; Strachan, GA | 1 |
Robson, P | 1 |
Durst, R; Rebaudengo-Rosca, P | 1 |
Ghuran, A; Nolan, J | 1 |
Pedersen, W; Skrondal, A | 1 |
Rodgers, J | 1 |
Baronti, R; Franceschini, E | 1 |
Harris, LS | 1 |
Becker, S; Daumann, J; Gouzoulis-Mayfrank, E; Pelz, S; Tuchtenhagen, F | 1 |
Parrott, A | 1 |
Fox, H; Milani, RM; Parrott, AC | 1 |
Dafters, RI; Hoshi, R; Talbot, AC | 1 |
Lafay, N; Padet, N; Senon, JL | 1 |
Daumann, J; Gouzoulis-Mayfrank, E; Hensen, G; Rezk, M; Thimm, B; Till, B | 1 |
Buchanan, T; Heffernan, TM; Ling, J; Parrott, AC; Rodgers, J; Scholey, AB | 1 |
Binsinger, C; Friser, A; Laure, P; Lecerf, T | 1 |
Darko, DA; Hillson, RM; Ng, RS | 1 |
Hogg, RS; Lampinen, TM; Rusch, M; Schilder, A | 1 |
Daumann, J; Fischermann, T; Gouzoulis-Mayfrank, E; Heekeren, K; Thron, A | 1 |
Daumann, J; Fischermann, T; Gouzoulis-Mayfrank, E; Heekeren, K; Henke, K; Thron, A | 1 |
Chrostek Maj, J; Kamenczak, A; Kroch, S; Polewka, A; Szerszeń-Motyka, J | 1 |
Gouzoulis-Meyfrank, E; Parrott, AC; Rodgers, J; Solowij, N | 1 |
Braida, D; Sala, M | 1 |
Frueh, BE; Goldblum, D; Trittibach, P | 1 |
Dafters, RI | 1 |
Rodriguez-Cruz, SE | 1 |
Firth, AY | 1 |
Chandler, MD; Fisk, JE; Montgomery, C; Murphy, PN; Wareing, M | 1 |
Lenné, MG | 1 |
Daumann, J; Gouzoulis-Mayfrank, E; Milani, RM; Parrott, AC | 1 |
Abanades, S; de la Torre, R; Farré, M; Langohr, K; Pacifici, R; Pichini, S; Poudevida, S; Segura, J; Zuccaro, P | 1 |
de Win, MM; Jager, G; Koeter, M; Korf, DJ; Schilt, T; Schmand, B; van den Brink, W | 1 |
Bolo, NR; Cowan, RL; Dietrich, M; Haga, E; Lukas, SE; Renshaw, PF | 1 |
Fisk, JE; Montgomery, C | 2 |
Kokkalis, J; Laws, KR | 1 |
de Win, MM; Jager, G; Koeter, MW; Ramsey, NF; Schilt, T; Schmand, B; van den Brink, W | 1 |
Bedi, G; Redman, J | 1 |
Hill, S; Thomas, SH | 1 |
Allott, K; Broadbear, JH; Canny, BK; Murphy, B; Redman, J; Stepto, NK | 1 |
Almirall, JR; Corbin, I; Lai, H | 1 |
Daamen, M; Glasmacher, C; Indlekofer, F; Lange, KW; Lieb, R; Pfister, H; Piechatzek, M; Schütz, CG; Tucha, O; Wittchen, HU | 1 |
Blakemore, C | 1 |
Bruhn, C | 1 |
Civit, E; Garcia-Algar, O; Joya, X; Papaseit, E; Pellegrini, M; Pichini, S; Scaravelli, G; Vall, O | 1 |
Blagrove, M; Jones, KA; Parrott, AC | 1 |
Buitelaar, JK; de Kam, M; Dumont, GJ; Touw, DJ; van Gerven, JM; van Hasselt, JG; Verkes, RJ | 1 |
Arendt, M; Jensen, SO; Munk-Jørgensen, P; Sher, L | 1 |
Bridges, N; Fisk, JE; Hadjiefthyvoulou, F; Montgomery, C | 1 |
Schilt, T; van Holst, RJ | 1 |
Schulz, S | 1 |
Ben Hamida, S; Cassel, JC; de Vasconcelos, AP; Jones, BC; Mohamed, WM | 1 |
Cuenca, A; Cuyàs, E; de la Torre, R; de Sola Llopis, S; Fagundo, AB; Farré, M; Khymenets, O; Langohr, K; Martín-Santos, R; Peña-Casanova, J; Rodríguez, J; Torrens, M; Verdejo-García, A | 1 |
Atherton, K; Brosnan, R; Grainger, J; Scholey, AB; Wetherell, MA | 1 |
Brown, J; Bruno, R; Murray, E | 1 |
Bellis, M; Broekaert, E; Lammertyn, J; Rosiers, J; Van Havere, T; Vanderplasschen, W | 1 |
Fernández-Serrano, MJ; Gómez-Río, M; Moreno-López, L; Pérez-García, M; Rodríguez-Fernández, A; Stamatakis, EA; Verdejo-García, A | 1 |
Flavel, SC; Koch, JD; Todd, G; White, JM | 1 |
Rodríguez-Árias, M; Valverde, O | 1 |
Fisk, JE; Gallagher, DT; Hadjiefthyvoulou, F; Judge, J; Montgomery, C; Robinson, SJ | 1 |
Barratt, MJ; Ferris, JA; Winstock, AR | 1 |
Flavel, SC; Pearson-Dennett, V; Thewlis, D; Todd, G; Vogel, AP; White, JM; Wilcox, RA | 1 |
Boels, D; Bretaudeau Deguigne, M; Bruneau, C; Harry, P; Le Roux, G; Lelièvre, B; Turcant, A | 1 |
Castiglioni, S; Gracia-Lor, E; Parabiaghi, A; Riva, F; Rousis, NI; Senta, I; Zuccato, E | 1 |
Caliskan, FT; Karcioglu, O; Temizyurek, Z; Toker, I; Toktas, R; Unek, O; Zirek, B | 1 |
Bade, R; Cooke, R; Gerber, C; Longo, M; Tscharke, BJ; White, JM | 1 |
Barratt, MJ; Bruno, R; Burns, L; Peacock, A; Roxburgh, A; Sutherland, R | 1 |
Graydon-Guy, T; Prasad, J; Romeo, JS; Rychert, M; Wilkins, C | 1 |
Bretteville-Jensen, AL; Furuhaugen, H; Gjerde, H; Gjersing, L | 1 |
Curran, VH; Kamboj, SK; O'Driscoll, C; Platt, B; Rendell, PG | 1 |
Burns, L; Esterman, A; Faulkner, PL; Pearson-Dennett, V; Thewlis, D; Todd, G; Vogel, AP; White, JM; Wilcox, RA | 1 |
Chiu, YC; Lin, C; Lin, YH; Lo, MT; Wong, BY | 1 |
Benoit, E; Campos, S; Elliott, L; Haddock, CK | 1 |
Borges, KB; Dos Santos, NA; Filho, JFA; Lacerda, V; Pelição, FS; Romão, W | 1 |
Cox, DJ; Johnson, MW | 1 |
Alexeev, S; Livingston, M; Weatherburn, D | 1 |
Coyer, L; Davidovich, U; Kelly, BC; Mustillo, SA; Prins, M | 1 |
Guzel, EY | 1 |
Haug, NA; Macia, KS; Sottile, JE; Wickham, RE | 1 |
Barrio, G; Belza, MJ; Donat, M; Guerras, JM; Hoyos, J; Pérez-Romero, C; Politi, J; Pulido, J; Regidor, E | 1 |
11 review(s) available for n-methyl-3,4-methylenedioxyamphetamine and humulene
Article | Year |
---|---|
A guide to non-opiate illicit drugs.
Topics: Adolescent; Cannabis; Central Nervous System Stimulants; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Solvents; Substance-Related Disorders | 1996 |
Recreational drug misuse: issues for the cardiologist.
Topics: Adolescent; Adult; Amphetamines; Cannabis; Cardiovascular Diseases; Child; Cocaine; Drug Overdose; Female; Hallucinogens; Heroin; Humans; Lysergic Acid Diethylamide; Male; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Psilocybin; Substance-Related Disorders | 2000 |
[Medication-induced psychoses].
Topics: Cannabis; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induced; Somatoform Disorders | 2003 |
Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interaction.
Topics: Animals; Cannabinoid Receptor Modulators; Cannabis; Drug Interactions; Endocannabinoids; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Reinforcement, Psychology; Reward | 2005 |
Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.
Topics: Animals; Cannabis; Cytoprotection; Drug Interactions; Fever; Hallucinogens; Humans; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Neurocognitive Disorders; Oxidative Stress; Risk Factors | 2007 |
Ecstasy (MDMA) and memory function: a meta-analytic update.
Topics: Cannabis; Databases, Factual; Hallucinogens; Humans; Illicit Drugs; Memory Disorders; Memory, Short-Term; Mental Recall; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Substance-Related Disorders | 2007 |
Drug-related decrease in neuropsychological functions of abstinent drug users.
Topics: Alcoholism; Amphetamine-Related Disorders; Cannabis; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Drug Users; Hallucinogens; Heroin Dependence; Humans; Marijuana Abuse; Memory Disorders; Methadone; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Opioid-Related Disorders; Psychomotor Performance; Recognition, Psychology; Substance-Related Disorders; Verbal Behavior | 2011 |
MDMA & cannabis: a mini-review of cognitive, behavioral, and neurobiological effects of co-consumption.
Topics: Animals; Body Temperature; Brain; Cannabinoids; Cannabis; Cognition; Conditioning, Psychological; Herb-Drug Interactions; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Synaptic Transmission | 2011 |
MDMA: interactions with other psychoactive drugs.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Caffeine; Cannabis; Central Nervous System Depressants; Cocaine; Drug Interactions; Ethanol; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Psychotropic Drugs; Substance-Related Disorders | 2011 |
Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid system.
Topics: Amphetamine-Related Disorders; Animals; Cannabinoids; Cannabis; Cognition Disorders; Endocannabinoids; Humans; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Reinforcement, Psychology; Reward; Time Factors | 2013 |
The effects of licit and illicit recreational drugs on prospective memory: a meta-analytic review.
Topics: Alcohol Drinking; Cannabis; Hallucinogens; Humans; Illicit Drugs; Memory Disorders; Memory, Episodic; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2019 |
4 trial(s) available for n-methyl-3,4-methylenedioxyamphetamine and humulene
Article | Year |
---|---|
Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
Topics: Adult; Amphetamine; Cannabis; Central Nervous System Stimulants; Cerebral Cortex; Dose-Response Relationship, Drug; Female; Hallucinogens; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory, Short-Term; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Oxygen; Reaction Time; Regression Analysis; Substance-Related Disorders | 2004 |
Evidence for selective executive function deficits in ecstasy/polydrug users.
Topics: Adult; Amphetamine-Related Disorders; Cannabis; Cocaine; Cognition; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Problem Solving; Tablets | 2009 |
Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.
Topics: Adult; Affect; Cannabis; Citalopram; Drug Users; Female; Humans; Hydrocortisone; Male; N-Methyl-3,4-methylenedioxyamphetamine; Personality; Prolactin; Selective Serotonin Reuptake Inhibitors; Sex Characteristics | 2009 |
Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers.
Topics: Administration, Inhalation; Adult; Cannabis; Cognition; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Interactions; Drug Therapy, Combination; Euphoria; Female; Humans; Male; Memory; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Placebos; Psychomotor Performance; Young Adult | 2011 |
67 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and humulene
Article | Year |
---|---|
View from the Nation's Capital. DEA considers relaxing restrictions on medical use of marijuana.
Topics: 3,4-Methylenedioxyamphetamine; Cannabis; Dronabinol; Drug and Narcotic Control; Humans; N-Methyl-3,4-methylenedioxyamphetamine; United States; United States Food and Drug Administration | 1988 |
A fatal overdose with 3,4-methylenedioxyamphetamine derivatives.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamines; Cannabinoids; Cannabis; Designer Drugs; Drug Overdose; Fatal Outcome; Humans; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Postmortem Changes; Substance-Related Disorders | 1994 |
[Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
Topics: Adult; Alcoholism; Attention Deficit Disorder with Hyperactivity; Cannabis; Central Nervous System Stimulants; Female; Humans; Lysergic Acid Diethylamide; Marijuana Abuse; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 1997 |
Ecstasy and new patterns of drug use: a normal population study.
Topics: Adolescent; Alcoholism; Amphetamines; Cannabis; Cohort Studies; Female; Hallucinogens; Heroin; Humans; Logistic Models; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norway; Prevalence; Smoking; Social Behavior; Substance-Related Disorders | 1999 |
Cognitive performance amongst recreational users of "ecstasy".
Topics: Adult; Attention; Cannabis; Cognition; Female; Hallucinogens; Humans; Illicit Drugs; Male; Memory; N-Methyl-3,4-methylenedioxyamphetamine; Reaction Time; Substance-Related Disorders | 2000 |
[Clinical aspects of abuse drugs mainly used by adolescents].
Topics: Adolescent; Adolescent Behavior; Age Factors; Amphetamine-Related Disorders; Amphetamines; Anti-Anxiety Agents; Cannabis; Cocaine; Cocaine-Related Disorders; Flunitrazepam; Hallucinogens; Heroin Dependence; Humans; Italy; N-Methyl-3,4-methylenedioxyamphetamine; Poisoning; Solvents; Substance-Related Disorders | 2001 |
Updates on students and their perceptions of risk associated with drug use.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Attitude; Cannabis; Child; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Risk; Students; Substance-Related Disorders | 2000 |
Drug dependence studies and regulations: an overview of the past and present.
Topics: Cannabis; Drug and Narcotic Control; Forecasting; History, 20th Century; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oxycodone; Sodium Oxybate; Substance-Related Disorders; United States | 2001 |
Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?
Topics: Adrenergic Uptake Inhibitors; Adult; Analysis of Variance; Cannabis; Female; Fenfluramine; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurosecretory Systems; Prolactin; Serotonin Agents; Time Factors | 2002 |
Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
Topics: Cannabis; Cognition; Cognition Disorders; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2003 |
Cannabis, ecstasy/MDMA and memory: a commentary on Simon & Mattick's recent study.
Topics: Cannabis; Hallucinogens; Humans; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine | 2003 |
Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.
Topics: Adult; Attention; Cannabis; Cognition; Drug Interactions; Female; Hallucinogens; Humans; Illicit Drugs; Male; Memory; N-Methyl-3,4-methylenedioxyamphetamine | 2004 |
Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
Topics: Adult; Cannabis; Cross-Sectional Studies; Drug Interactions; Female; Hallucinogens; Humans; Illicit Drugs; Longitudinal Studies; Male; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psychiatric Status Rating Scales | 2004 |
Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
Topics: Amphetamine-Related Disorders; Cannabis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hallucinogens; Humans; Internet; Male; Memory; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Sex Factors; Surveys and Questionnaires; Time Factors | 2003 |
Drugs, recreational drug use and attitudes towards doping of high school athletes.
Topics: Adolescent; Alcohols; Cannabis; Doping in Sports; Female; France; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nicotiana; Psychology, Adolescent; Schools; Sports; Students; Substance-Related Disorders; Surveys and Questionnaires; Tranquilizing Agents | 2004 |
Street drug use among young patients with Type 1 diabetes in the UK.
Topics: Adolescent; Adult; Cannabis; Cocaine; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Dopamine Uptake Inhibitors; Hallucinogens; Heroin; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Prevalence; Substance-Related Disorders; Surveys and Questionnaires; United Kingdom | 2004 |
Unprotected anal intercourse associated with recreational drug use among young men who have sex with men depends on partner type and intercourse role.
Topics: Adult; Alcohol Drinking; British Columbia; Cannabis; Cohort Studies; HIV Infections; Homosexuality, Male; Humans; Ketamine; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prospective Studies; Safe Sex; Sexual Partners; Substance-Related Disorders | 2004 |
Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
Topics: Adult; Amphetamine; Brain Mapping; Cannabis; Female; Hallucinogens; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Oxygen; Reaction Time; Substance-Related Disorders | 2005 |
[Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units].
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Cannabis; Cocaine; Cocaine-Related Disorders; Female; Hospitalization; Humans; Male; Marijuana Abuse; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Opioid-Related Disorders; Poland; Psychotropic Drugs; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome | 2004 |
Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects.
Topics: Cannabis; Drug Interactions; Hallucinogens; Humans; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Substance-Related Disorders | 2004 |
Bilateral angle-closure glaucoma after combined consumption of "ecstasy" and marijuana.
Topics: Adult; Cannabis; Emergency Medicine; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Illicit Drugs; Intraocular Pressure; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Ophthalmology; Substance-Related Disorders; Treatment Outcome; Visual Acuity | 2005 |
Impulsivity, inhibition and negative priming in ecstasy users.
Topics: Adult; Cannabis; Cognition Disorders; Female; Humans; Impulsive Behavior; Inhibition, Psychological; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Prevalence | 2006 |
Rapid analysis of controlled substances using desorption electrospray ionization mass spectrometry.
Topics: Acetaminophen; Alprazolam; Cannabis; Drug Combinations; Hydrocodone; Legislation, Drug; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Prednisone; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Time Factors | 2006 |
Editorial: ocular effects of criminal drug use.
Topics: Cannabis; Cocaine; Eye Diseases; Heroin; Humans; Illicit Drugs; Lysergic Acid Diethylamide; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2006 |
Information processing speed in ecstasy (MDMA) users.
Topics: Adult; Amphetamine; Cannabis; Cocaine; Ethanol; Humans; Memory; Mental Processes; Multivariate Analysis; N-Methyl-3,4-methylenedioxyamphetamine; Pattern Recognition, Visual; Psychomotor Performance; Reproducibility of Results; Self Administration; Substance-Related Disorders; Surveys and Questionnaires; Time Factors | 2007 |
Roadside drug testing: unanswered questions and future challenges.
Topics: Australia; Automobile Driving; Breath Tests; Cannabis; Forecasting; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Substance-Related Disorders | 2007 |
Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans.
Topics: Adult; Cannabis; Drug Interactions; Female; Follow-Up Studies; Hallucinogens; Humans; Immunity, Cellular; Immunologic Factors; Interleukin-2; Longitudinal Studies; Lymphocytes; Male; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Transforming Growth Factor beta1 | 2007 |
Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
Topics: Adult; Attention; Cannabis; Cognition; Cognition Disorders; Cohort Studies; Female; Follow-Up Studies; Humans; Illicit Drugs; Male; Memory; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Neuropsychological Tests; Prospective Studies; Risk Factors; Substance-Related Disorders; Verbal Behavior | 2007 |
Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users.
Topics: Adolescent; Adult; Amphetamines; Analgesics, Opioid; Aspartic Acid; Cannabis; Cocaine; Female; Hallucinogens; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; N-Methyl-3,4-methylenedioxyamphetamine; Occipital Lobe; Protons; Radiography; Substance-Related Disorders | 2007 |
Everyday memory deficits in ecstasy-polydrug users.
Topics: Adult; Cannabis; Cognition Disorders; Female; Hallucinogens; Humans; Illicit Drugs; Linear Models; Male; Memory; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Surveys and Questionnaires | 2007 |
Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
Topics: Adolescent; Adult; Amphetamine; Attention; Cannabis; Central Nervous System Stimulants; Cocaine; Cognition; Cognition Disorders; Female; Hallucinogens; Humans; Illicit Drugs; Male; Memory, Short-Term; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Neuropsychological Tests; Space Perception; Substance-Related Disorders; Verbal Behavior; Visual Perception | 2008 |
Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
Topics: Adult; Affect; Attention; Cannabis; Cognition; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Memory; Memory, Short-Term; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Predictive Value of Tests; Severity of Illness Index; Students; Substance-Related Disorders; Verbal Behavior | 2008 |
Recreational drug toxicity.
Topics: Amphetamines; Benzodiazepines; Cannabis; Cocaine; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Naloxone; Narcotic Antagonists; Piperazines; Sodium Oxybate; Substance-Related Disorders | 2008 |
Headspace sampling and detection of cocaine, MDMA, and marijuana via volatile markers in the presence of potential interferences by solid phase microextraction-ion mobility spectrometry (SPME-IMS).
Topics: Air; Cannabis; Cocaine; Dimethylpolysiloxanes; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Solid Phase Microextraction; Substance Abuse Detection | 2008 |
Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
Topics: Adult; Alcohol Drinking; Attention; Cannabis; Cognition; Dose-Response Relationship, Drug; Female; Hallucinogens; Humans; Illicit Drugs; Linear Models; Male; Marijuana Abuse; Memory; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Substance-Related Disorders; Young Adult | 2009 |
Classification of cannabis and ecstasy in the UK.
Topics: Cannabis; Hallucinogens; Humans; Legislation, Drug; N-Methyl-3,4-methylenedioxyamphetamine; United Kingdom | 2009 |
[How dangerous are the "new drugs"?].
Topics: Cannabis; Humans; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders | 2009 |
Unsuspected exposure to cocaine in preschool children from a Mediterranean city detected by hair analysis.
Topics: Amphetamines; Cannabis; Child; Cocaine; Female; Gas Chromatography-Mass Spectrometry; Hair; Humans; Infant, Newborn; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Pregnancy; Prenatal Exposure Delayed Effects; Smoking; Social Class; Spain; Substance Abuse Detection; Substance-Related Disorders | 2009 |
Cannabis and Ecstasy/ MDMA: empirical measures of creativity in recreational users.
Topics: Adult; Cannabis; Creativity; Female; Humans; Intelligence; Male; N-Methyl-3,4-methylenedioxyamphetamine; Sex Characteristics | 2009 |
Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment.
Topics: Adult; Amphetamine; Analgesics, Opioid; Cannabis; Cocaine; Cohort Studies; Denmark; Female; Follow-Up Studies; Humans; Male; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Registries; Substance-Related Disorders; Treatment Outcome; Young Adult | 2011 |
Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).
Topics: Amphetamine-Related Disorders; Cannabis; Case-Control Studies; Female; Humans; Male; Marijuana Abuse; Memory; Memory Disorders; Memory, Long-Term; N-Methyl-3,4-methylenedioxyamphetamine; Psychological Tests; Retention, Psychology; Substance-Related Disorders; Surveys and Questionnaires | 2011 |
The influence of genetic and environmental factors among MDMA users in cognitive performance.
Topics: Attention; Cannabis; Cognition; Dose-Response Relationship, Drug; Environment; Female; Genotype; Humans; Male; Memory, Short-Term; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Polymorphism, Genetic; Semantics; Substance-Related Disorders; Young Adult | 2011 |
The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA.
Topics: Adult; Affect; Age Factors; Cannabis; Female; Hallucinogens; Humans; Male; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Stress, Psychological; Substance-Related Disorders; Workload; Young Adult | 2012 |
Residual effects of ecstasy (3,4-methylenedioxymethamphetamine) on low level visual processes.
Topics: Adolescent; Adult; Cannabis; Case-Control Studies; Female; Figural Aftereffect; Hallucinogens; Humans; Male; Marijuana Smoking; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Orientation; Photic Stimulation; Substance-Related Disorders; Visual Perception; Young Adult | 2012 |
Illicit drug use in the flemish nightlife scene between 2003 and 2009.
Topics: Adolescent; Adult; Amphetamines; Belgium; Cannabis; Cocaine; Drug Users; Female; Humans; Hydroxybutyrates; Illicit Drugs; Ketamine; Life Style; Longitudinal Studies; Male; N-Methyl-3,4-methylenedioxyamphetamine; Recreation; Social Behavior; Social Perception; Social Problems; Young Adult | 2012 |
Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study.
Topics: Adult; Brain; Cannabis; Cocaine; Demography; Ethanol; Female; Heroin; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Rest; Substance-Related Disorders | 2012 |
Illicit stimulant use in humans is associated with a long-term increase in tremor.
Topics: Adolescent; Adult; Amphetamines; Cannabis; Drug Users; Female; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Tremor; Young Adult | 2012 |
Prospective memory deficits in illicit polydrug users are associated with the average long-term typical dose of ecstasy typically consumed in a single session.
Topics: Adult; Cannabis; Female; Humans; Male; Memory; Memory, Episodic; N-Methyl-3,4-methylenedioxyamphetamine; Young Adult | 2014 |
Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States.
Topics: Adult; Australia; Cannabis; Data Collection; Drug Trafficking; Female; Humans; Illicit Drugs; Internet; Logistic Models; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; United Kingdom; United States; Young Adult | 2014 |
Hand function is altered in individuals with a history of illicit stimulant use.
Topics: Adolescent; Adult; Cannabis; Female; Hand; Hand Strength; Humans; Illicit Drugs; Lifting; Male; Methamphetamine; Middle Aged; Motor Skills; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Young Adult | 2014 |
Recreational phenethylamine poisonings reported to a French poison control center.
Topics: Adolescent; Adult; Alkaloids; Amphetamine; Cannabis; Child; Drug Interactions; Ethanol; Female; France; Hospitalization; Humans; Intensive Care Units; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Poison Control Centers; Prevalence; Retrospective Studies; Symptom Assessment; Young Adult | 2015 |
Illicit drug consumption in school populations measured by wastewater analysis.
Topics: Amphetamine; Cannabinoids; Cannabis; Cocaine; Humans; Illicit Drugs; Italy; Ketamine; Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Substance-Related Disorders; Wastewater | 2017 |
Street drug use among emergency patients in a Public Hospital in Turkey.
Topics: Adolescent; Adult; Cannabis; Child; Consciousness Disorders; Emergency Service, Hospital; Female; Hospitals, Public; Humans; Illicit Drugs; Male; Middle Aged; Muscle Weakness; N-Methyl-3,4-methylenedioxyamphetamine; Patient Admission; Resuscitation; Substance-Related Disorders; Turkey; Young Adult | 2018 |
Investigating the correlation between wastewater analysis and roadside drug testing in South Australia.
Topics: Cannabinoids; Cannabis; Driving Under the Influence; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Police; Reproducibility of Results; South Australia; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Wastewater | 2018 |
Typology of new psychoactive substance use among the general Australian population.
Topics: Adolescent; Adult; Amphetamine; Australia; Cannabinoids; Cannabis; Cocaine; Female; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Population Surveillance; Psychotropic Drugs; Substance-Related Disorders; Young Adult | 2018 |
Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cannabinoids; Cannabis; Female; Humans; Illicit Drugs; Lysergic Acid Diethylamide; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; New Zealand; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2018 |
Illegal substance use among 1,309 music festival attendees: An investigation using oral fluid sample drug tests, breathalysers and questionnaires.
Topics: Adolescent; Adult; Blood Alcohol Content; Breath Tests; Cannabis; Cross-Sectional Studies; Female; Humans; Illicit Drugs; Male; Music; N-Methyl-3,4-methylenedioxyamphetamine; Norway; Saliva; Substance Abuse Detection; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2019 |
Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Brain; Cannabis; Central Nervous System Stimulants; Female; Hallucinogens; Humans; Logistic Models; Male; Methamphetamine; Movement Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Self Report; Young Adult | 2019 |
Development of an addiction index and delineation 15-year trends of illicit drugs from the Taiwan national drug enhancement database.
Topics: Amphetamine-Related Disorders; Anesthetics, Dissociative; Cannabis; Central Nervous System Stimulants; Crime; Databases, Factual; Hallucinogens; Heroin; Humans; Illicit Drugs; Ketamine; Marijuana Abuse; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Opioid-Related Disorders; Psychiatric Status Rating Scales; Substance-Related Disorders; Taiwan | 2020 |
Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities.
Topics: Cannabis; Cities; Cluster Analysis; Cocaine; Female; Heroin; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; United States | 2019 |
Fiber spray ionization mass spectrometry in forensic chemistry: A screening of drugs of abuse and direct determination of cocaine in urine.
Topics: Analgesics, Opioid; Cannabinoids; Cannabis; Cocaine; Forensic Sciences; Humans; Illicit Drugs; Limit of Detection; Mass Spectrometry; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Solvents; Substance Abuse Detection; Tablets | 2020 |
Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.
Topics: Cannabis; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Verbal Behavior | 2022 |
Changes in and correlates of Australian public attitudes toward illicit drug use.
Topics: Australia; Cannabis; Cocaine; Hallucinogens; Heroin; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2022 |
Changes in substance use among HIV-negative MSM: A longitudinal analysis, 1995-2019.
Topics: Cannabis; Cocaine; Cohort Studies; HIV Infections; Homosexuality, Male; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Risk-Taking; Sexual and Gender Minorities; Sexual Behavior; Substance-Related Disorders; Surveys and Questionnaires | 2022 |
Monitoring of changes in illicit drugs, alcohol, and nicotine consumption during Ramadan via wastewater analysis.
Topics: Amphetamine; Cannabis; Cocaine; Ethanol; Heroin; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Substance Abuse Detection; Wastewater; Water Pollutants, Chemical | 2022 |
Development and initial validation of an MDMA/Ecstasy motives assessment.
Topics: Adult; Affect; Cannabis; Hallucinogens; Humans; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine | 2023 |
Abrupt peaks in perceived risk of occasional drug use after changing the question order in a repeated self-administered survey.
Topics: Adolescent; Affect; Cannabis; Cocaine; Heroin; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2023 |